drugset / Trial / NCT01507922

Comparative Efficacy and Safety of Fenoverine

NCT01507922 ↗

Phase 4 Completed 186 enrolled Bukwang Pharmaceutical
RandomizedParallel-groupQuadruple-blindTreatment

Summary

It is a randomized double-blind parallel phase IV study to compare Fenoverine and Trimebutine maleate in the efficacy and safety. Study Hypothesis: Fenoverine is non-inferior to Trimebutine maleate in its efficacy and safety.

Timeline

Start
2011-12
Primary completion
2013-03
Completion
2013-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Fenoverine Small molecule 100 mg Oral
Comparator Timebutine Unknown 150 mg Oral